課程資訊
課程名稱
博士專題研究
Seminar 
開課學期
108-1 
授課對象
醫學工程學研究所  
授課教師
謝銘鈞 
課號
DBME8001 
課程識別碼
528 D0020 
班次
10 
學分
1.0 
全/半年
半年 
必/選修
必修 
上課時間
 
上課地點
 
備註
本課程中文授課,使用英文教科書。
總人數上限:20人 
Ceiba 課程網頁
http://ceiba.ntu.edu.tw/1081DBME8001_10 
課程簡介影片
 
核心能力關聯
核心能力與課程規劃關聯圖
課程大綱
為確保您我的權利,請尊重智慧財產權及不得非法影印
課程概述

博士專題研究:進度報告與文獻分享 

課程目標
引導學生完成研究成果 
課程要求
1.每星期挑選一主題報告與同學進行討論。 2.同學分享每星期實驗進度並由老師給予改善建議。 
預期每週課後學習時數
 
Office Hours
每週二 17:30~19:30 
指定閱讀
N/A 
參考書目
N/A 
評量方式
(僅供參考)
 
No.
項目
百分比
說明
1. 
出席狀況 
30% 
 
2. 
實驗記錄 
30% 
 
3. 
口頭報告 
40% 
 
 
課程進度
週次
日期
單元主題
第1週
2019/9/10   暫停一次 
第2週
2019/9/17  欣瑜-Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study.
芮安-Nanoparticle co-delivery of wortmannin and cisplatin synergistically enhances chemoradiotherapy and reverses platinum resistance in ovarian cancer models.
淑娟-Excipient-free nanodispersion of 7-ethyl-10-hydroxycamptothecin exerts potent therapeutic effects against pancreatic cancer cell lines and patient- derived xenografts.
[核心能力:1,2,4,6] 
第3週
2019/9/24  仲歡-Eradication Efficacy of Modified Dual Therapy Compared with Bismuth-Containing Quadruple Therapy as a First- Line Treatment of Helicobacter pylori.
筱婷-An Imagable and Photothermal “Abraxane-Like” Nanodrug for Combination Cancer Therapy to Treat Subcutaneous and Metastatic Breast Tumors.
[核心能力:1,2,4,6] 
第4週
2019/10/1  芮安-A triple-synergistic strategy for combinational photo/radiotherapy and multi-modality imaging based on hyaluronic acid-hybridized polyaniline-coated WS2 nanodots.
欣瑜-T98G Cell Death Induced by Photothermal Treatment with Hollow Gold Nanoshell-Coupled Silica Microrods Prepared from Escherichia Coli.
[核心能力:1,2,4,6] 
第5週
2019/10/8  淑娟-Amphiphilic drugs as surfactants to fabricate excipient-free stable nanodispersions of hydrophobic drugs for cancer chemotherapy.
筱婷-One-pot synthesis of polypyrrole nanoparticles with tunable photothermal conversion and drug loading capacity.
[核心能力:1,2,4,6] 
第6週
2019/10/15  芮安-Development of a hypoxia-triggered and hypoxic radiosensitized liposome as a doxorubicin carrier to promote synergetic chemo-/ radio-therapy for glioma.
欣瑜-VIPERnano : Improved live cell intracellular protein tracking.
[核心能力:1,2,4,6] 
第7週
2019/10/22  謝醫師出國,group meeting暫停一週 
第8週
2019/10/29  仲歡-Chitosan Nanoparticles-Mediated pCDNA3.1(–)-hcpD DNA Vaccine against Helicobacter pylori in BALB/c Mice. 淑娟-One-step mechanochemical preparation and prominent antitumor activity of SN-38 self-micelle solid dispersion.
[核心能力:1,2,4,6] 
第9週
2019/11/05  期中考週 暫停一次 
第10週
2019/11/12  筱婷-SN38 polymeric nanoparticles: In vitro cytotoxicity and in vivo antitumor efficacy in xenograft balb/c model with breast cancer versus irinotecan.
芮安-A nuclear-targeted titanium dioxide radiosensitizer for cell cycle regulation and enhanced radiotherapy.
[核心能力:1,2,4,6] 
第11週
2019/11/19  謝醫師出國,暫停一次 
第12週
2019/11/26  淑娟- Electrochemotherapy with cisplatin increases survival and induces immunogenic responses in murine models of lung cancer and colorectal cancer.
仲歡- Low-Molecular-Weight Dextran Sulfate Nanocapsules Inhibit the Adhesion of Helicobacter pylori to Gastric Cells.
[核心能力:1,2,4,6]
 
第13週
2019/12/3  暫停一次 
第14週
2019/12/10  芮安- All-in-One Theranostic Nanoplatform Based on Hollow TaOx for Chelator-Free Labeling Imaging, Drug Delivery, and Synergistically Enhanced Radiotherapy.
筱婷- Multi-responsive albumin-lonidamine conjugated hybridized gold nanoparticle as a combined photothermal-chemotherapy for synergistic tumor ablation.
[核心能力:1,2,4,6] 
第15週
2019/12/17  暫停一次 
第16週
2019/12/24  淑娟- Macrophage Inflammatory Protein Derivative ECI301 Enhances the Alarmin-Associated Abscopal Benefits of Tumor Radiotherapy.
仲歡- Chitosan-albumin based core shell-corona nano-antimicrobials to eradicate resistant gastric pathogen.
[核心能力:1,2,4,6] 
第17週
2019/12/31  暫停一次 
第18週
2020/01/07  芮安- pH-Sensitive Dissociable Nanoscale Coordination Polymers with Drug Loading for Synergistically Enhanced Chemoradiotherapy.
筱婷- Molecular Targeting-Mediated Mild-Temperature Photothermal Therapy with a Smart Albumin-Based Nanodrug.
[核心能力:1,2,4,6]